Frontier Capital Management Co. LLC lowered its stake in Innophos Holdings, Inc. (NASDAQ:IPHS) by 0.1% during the second quarter, according to its most recent filing with the SEC. The firm owned 856,430 shares of the specialty chemicals company’s stock after selling 1,226 shares during the period. Frontier Capital Management Co. LLC owned 4.42% of Innophos Holdings worth $37,546,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Teachers Advisors LLC boosted its position in Innophos Holdings by 23.9% in the fourth quarter. Teachers Advisors LLC now owns 53,259 shares of the specialty chemicals company’s stock valued at $2,783,000 after buying an additional 10,266 shares during the last quarter. Personal Capital Advisors Corp boosted its position in Innophos Holdings by 9.6% in the first quarter. Personal Capital Advisors Corp now owns 110,646 shares of the specialty chemicals company’s stock valued at $5,939,000 after buying an additional 9,717 shares during the last quarter. Morgan Stanley boosted its position in Innophos Holdings by 16.8% in the first quarter. Morgan Stanley now owns 172,423 shares of the specialty chemicals company’s stock valued at $9,306,000 after buying an additional 24,858 shares during the last quarter. New York State Teachers Retirement System boosted its position in Innophos Holdings by 11.3% in the first quarter. New York State Teachers Retirement System now owns 22,602 shares of the specialty chemicals company’s stock valued at $1,220,000 after buying an additional 2,300 shares during the last quarter. Finally, Rational Advisors LLC purchased a new position in Innophos Holdings during the first quarter valued at $335,000. Hedge funds and other institutional investors own 94.76% of the company’s stock.

Innophos Holdings, Inc. (NASDAQ IPHS) opened at 44.50 on Monday. The company has a market cap of $863.12 million, a PE ratio of 19.43 and a beta of 0.85. Innophos Holdings, Inc. has a 52-week low of $37.02 and a 52-week high of $58.22. The firm’s 50-day moving average price is $44.27 and its 200 day moving average price is $46.88.

Innophos Holdings (NASDAQ:IPHS) last posted its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.05. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. The firm had revenue of $179.14 million during the quarter, compared to analysts’ expectations of $172.65 million. During the same period in the prior year, the business earned $0.63 EPS. The company’s revenue for the quarter was down 1.5% compared to the same quarter last year. On average, equities analysts predict that Innophos Holdings, Inc. will post $2.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 6th. Stockholders of record on Friday, August 18th will be issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.31%. The ex-dividend date is Wednesday, August 16th. Innophos Holdings’s payout ratio is currently 84.21%.

TRADEMARK VIOLATION WARNING: This news story was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/21/frontier-capital-management-co-llc-sells-1226-shares-of-innophos-holdings-inc-iphs.html.

IPHS has been the topic of several recent research reports. Zacks Investment Research upgraded Innophos Holdings from a “hold” rating to a “strong-buy” rating and set a $54.00 price objective on the stock in a research report on Tuesday, August 8th. Sidoti upgraded Innophos Holdings from a “neutral” rating to a “buy” rating in a research report on Friday, May 26th. They noted that the move was a valuation call. Finally, BidaskClub cut Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th.

About Innophos Holdings

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos Holdings (NASDAQ:IPHS)

Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.